相关实验视频

Updated: Jun 6, 2025

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

可以通过在黑色素瘤中引起I型干扰素信号来改善抗PD-L1免疫疗法

Xiaoxin Zhang¹, Jianhua Deng¹, Renjie Wu¹

¹State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan, China.

Investigational new drugs

|November 26, 2024

概括

将抗PD-L1免疫疗法与MnCl2结合起来,对黑色素瘤治疗有望. 这种组合增强T细胞透和树突细胞成熟,导致更强的抗瘤免疫反应和改善的瘤抑制与单独抗PD-L1相比.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
药理学药理学是指药理学的学科.

背景情况:

针对编程细胞死亡蛋白1/编程细胞死亡连接体1 (PD-1/PD-L1) 的免疫疗法已在黑色素瘤治疗中取得了进展.
然而,对于许多黑色素瘤患者来说,单独抗PD-L1治疗的疗效仍然不足于最佳水平.

研究的目的:

调查抗PD-L1单疗法在黑色素瘤中的局限性.
评估将抗PD-L1与化 (MnCl2) 结合的治疗潜力和潜在的分子机制.

主要方法:

在抗PD-L1治疗后的一种黑色素瘤异种移植小鼠模型中评估了免疫细胞群变化.
在实验室中研究了MnCl2对树突细胞 (DC) 成熟的影响.
评估了抗PD-L1和MnCl2治疗的联合治疗疗效和瘤微环境调制.

主要成果:

抗PD-L1治疗表现出一些瘤抑制活性,增加CD4+和CD8+T细胞计数,但没有显著影响DC数量.
在实验室中,MnCl2通过cGAS-STING信号通路显著促进了DC成熟.
组合疗法在异种移植模型中表现出优异的瘤抑制,增强T细胞透和DC成熟,表明强大的抗瘤免疫反应.

结论:

抗PD-L1和MnCl2的组合代表了增强黑色素瘤抗瘤免疫力的有希望的治疗策略.
MnCl2促进DC成熟的能力是促进与抗PD-L1疗法的协同效应的关键机制.

关键词:

抗PD-L1的抗PD-L1 的这里是DCs DCs DCs.黑色素瘤是一种黑色素瘤.在 MnCl2Cl2 中.在T细胞,T细胞.

更多相关视频

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.